Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting 30-Day Readmission After Stroke: A Systematic Review and Meta-Analysis to Inform Predictor Selection.

Diagnostics (Basel, Switzerland)·2026
Same author

Post-daunorubicin treatment effects on cardiovascular function in the Ts65Dn mouse model of Down syndrome.

bioRxiv : the preprint server for biology·2026
Same author

Sodium Channel mRNA Binding Proteins.

JACC. Basic to translational science·2026
Same author

Cardiac remodeling and arrhythmia in a mouse model of Depdc5 haploinsufficiency.

Epilepsia·2026
Same author

Neighborhood economic and demographic landscape as predictors of 90-day outcomes post-stroke hospitalization.

Frontiers in stroke·2026
Same author

Sodium Channel Isoform Diversity Underlies Chamber-Specific Cardiac Excitability.

Circulation research·2026
Same journal

Emerging Role of Statin Therapy in Preventing Anthracycline-Induced Cardiotoxicity.

Cardiology research and practice·2026
Same journal

Phenotypic Age Acceleration as a Mediator in Thyroid Hormone-Related Cardiovascular Risk Among the Elderly.

Cardiology research and practice·2026
Same journal

Applicability of Stress Cardiac Magnetic Resonance Imaging in Patients With Cardiac Implantable Devices: A Systematic Review.

Cardiology research and practice·2026
Same journal

Latest Management of Cardiac Sarcoidosis: A Comprehensive Review.

Cardiology research and practice·2026
Same journal

Predictive Equation for Peak Heart Rate and First Ventilatory Threshold Heart Rate in Patients With Coronary Heart Disease.

Cardiology research and practice·2026
Same journal

Electroacupuncture Protects Against Post-MI Heart Failure Through Autonomic Regulation and α7nAChR Activation.

Cardiology research and practice·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins Decrease Oxidative Stress and ICD Therapies.

Heather L Bloom1, Irfan Shukrullah, Emir Veledar

  • 1Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.

Cardiology Research and Practice
|April 7, 2010
PubMed
Summary
This summary is machine-generated.

Statins reduce ventricular arrhythmias in patients with implantable cardioverter-defibrillators (ICDs) by decreasing oxidative stress, measured by DROMs (derivatives of reactive oxygen species). This suggests statins

Related Experiment Videos

Last Updated: Jun 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Ventricular arrhythmias in ICD patients are linked to increased inflammation and oxidative stress.
  • The mechanism by which statins reduce these arrhythmias is not fully understood.

Purpose of the Study:

  • To investigate the hypothesis that statin use decreases oxidation, thereby reducing ventricular arrhythmias in ICD patients.
  • To explore the relationship between statin use, oxidative stress markers, and arrhythmia events.

Main Methods:

  • A survey of 304 ICD patients assessed ventricular arrhythmia events.
  • Blood samples were analyzed for derivatives of reactive oxygen species (DROMs) and interleukin-6 (IL-6).
  • Statistical analyses, including multivariate regression, were used to determine associations.

Main Results:

  • Statin use correlated with lower ICD events (P = .02) and reduced DROM levels (P = .03).
  • Subjects on statins had lower hsCRP levels (P = .05).
  • DROMs emerged as the dominant predictor of ICD events in multivariate regression analysis.

Conclusions:

  • ICD event rates correlate with DROMs, a marker of lipid peroxides.
  • Statin use is associated with lower DROMs and fewer ICD events.
  • Statins may exert their antiarrhythmic effect by reducing oxidative stress.